Biography

Although born in England, Dr Toby Helliwell lived most of his Childhood in Zambia where he developed a keen desire to become a doctor. This was realised after completing his undergraduate medical degree at Birmingham University. Subsequently he worked in various areas of the UK and also in Australia and completed his GP vocational training I was after being accepted onto the North Staffordshire academic vocational training scheme for general practitioners. He now works as a GP partner in North Staffordshire where he also teaches and mentors undergraduate students in a general practice setting. During his academic career he has completed a Masters degree in medicine and a PhD in musculoskeletal general practice. He is now a senior lecturer at Keele University, a fellow of the Royal College of General Practitioners and works as a research scholar for the clinical research network as well as being part of the global health team at Keele University having been part of the team since its inception. He has helped develop formal partnerships with institutions in Eastern and Southern Africa and South and East Asia.

Research and scholarship

Being a GP researcher his interests are wide, generally encompassing non-communicable disease which is fast becoming the predominant health challenge throughout the world particularly in resource poor settings. His main focus has however, been in researching improving care for patients in the community, particularly around painful and disabling musculoskeletal conditions. He has also developed an interest in metal health which is often a much stigmatised issue with little or no access to help in many parts of the world but can significantly impact on peoples livelihoods at multiple levels if not recognised and treated appropriately.

Teaching

Teaching activities are again broad, encompassing undergraduate, postgraduate GP trainees and supervision of two PhD students as well as an MPhil student. He has delivered teaching and clinical updates to patients, generalists and specialists through national and international platforms and conferences.

Selected Publications

  • Abdul Sultan A, Mallen C, Muller S, Hider S, Scott I, Helliwell T, Hall L. 2019. Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control study. BMC Medicine, vol. 17, Article 154. doi> link> full text>
  • Kwok CS, Seferovic PM, Van Spall HG, Helliwell T, Clarson L, Lawson C, Kontopantelis E, Patwala A, Duckett S, Fung E, Mallen CD, Mamas MA. 2019. Early Unplanned Readmissions After Admission to Hospital With Heart Failure. Am J Cardiol, vol. 124(5), 736-745. link> doi> full text>
  • Hider SL, Muller S, Helliwell T, Prior JA, Scott I, Lawton SA, Zwierska I, van Schaardenburg D, van der Helm-van Mil A, Raza K, Mallen CD. 2019. Symptoms associated with inflammatory arthritis are common in the primary care population: results from the joint symptoms survey. Rheumatology (Oxford). link> doi> full text>
  • Partington R, Helliwell T, Muller S, Abdul Sultan A, Mallen C. 2018. Comorbidities in polymyalgia rheumatica: a systematic review. Arthritis Res Ther, vol. 20(1), 258. link> doi> full text>
  • Helliwell T, Muller S, Hider SL, Zwierska I, Lawton S, Richardson J, Mallen C. 2018. Challenges of diagnosing and managing polymyalgia rheumatica: a multi-methods study in UK general practice. Br J Gen Pract, vol. 68(676), e783-e793. link> doi>

Full Publications List show

Journal Articles

  • Abdul Sultan A, Mallen C, Muller S, Hider S, Scott I, Helliwell T, Hall L. 2019. Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control study. BMC Medicine, vol. 17, Article 154. doi> link> full text>
  • Kwok CS, Seferovic PM, Van Spall HG, Helliwell T, Clarson L, Lawson C, Kontopantelis E, Patwala A, Duckett S, Fung E, Mallen CD, Mamas MA. 2019. Early Unplanned Readmissions After Admission to Hospital With Heart Failure. Am J Cardiol, vol. 124(5), 736-745. link> doi> full text>
  • Hider SL, Muller S, Helliwell T, Prior JA, Scott I, Lawton SA, Zwierska I, van Schaardenburg D, van der Helm-van Mil A, Raza K, Mallen CD. 2019. Symptoms associated with inflammatory arthritis are common in the primary care population: results from the joint symptoms survey. Rheumatology (Oxford). link> doi> full text>
  • Partington R, Helliwell T, Muller S, Abdul Sultan A, Mallen C. 2018. Comorbidities in polymyalgia rheumatica: a systematic review. Arthritis Res Ther, vol. 20(1), 258. link> doi> full text>
  • Helliwell T, Muller S, Hider SL, Zwierska I, Lawton S, Richardson J, Mallen C. 2018. Challenges of diagnosing and managing polymyalgia rheumatica: a multi-methods study in UK general practice. Br J Gen Pract, vol. 68(676), e783-e793. link> doi>
  • Partington RJ, Muller S, Helliwell T, Mallen CD, Abdul Sultan A. 2018. Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study. Ann Rheum Dis, vol. 77(12), 1750-1756. link> doi> full text>
  • Tshimologo M, Helliwell T, Hider S, Mallen C, Muller S. 2019. The availability of health information to patients with newly diagnosed polymyalgia rheumatica: results from the Polymyalgia Rheumatica (PMR) Cohort study. Prim Health Care Res Dev, vol. 20, e8. link> doi> full text>
  • Muller S, O'Brien A, Helliwell T, Hay CA, Gilbert K, Mallen CD, Busby K, PMRGCAuk. 2018. Support available for and perceived priorities of people with polymyalgia rheumatica and giant cell arteritis: results of the PMRGCAuk members' survey 2017. Clin Rheumatol, vol. 37(12), 3411-3418. link> doi> full text>
  • Muller S, Hider S, Helliwell T, Partington R, Mallen C. 2018. The real evidence for polymyalgia rheumatic as a paraneoplastic syndrome. Reumatismo, vol. 70(2), 118-119. link> doi> full text>
  • Sultan AA, Whittle R, Muller S, Roddy E, Mallen CD, Bucknall M, Helliwell T, Hider S, Paskins Z. 2018. Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy. CMAJ, vol. 190(19), E581-E587. link> doi> full text>
  • Muller S, Hider S, Helliwell T, Partington R, Mallen C. 2018. The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome. Reumatismo, vol. 70(1), 23-34. link> doi> full text>
  • Paskins Z, Whittle R, Abdul Sultan A, Muller S, Blagojevic-Bucknall M, Helliwell T, Packham J, Hider S, Roddy E, Mallen C. 2018. Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study. Osteoporos Int, vol. 29(7), 1659-1664. link> doi> full text>
  • Helliwell T, Muller S, Hider SL, Prior JA, Richardson JC, Mallen CD. 2018. Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods study. BMJ Open, vol. 8(2), e019320. link> doi> full text>
  • Mallen CD, Helliwell T, Scott IC. 2018. How can primary care physicians enhance the early diagnosis of rheumatic diseases?. Expert Rev Clin Immunol, vol. 14(3), 171-173. link> doi> full text>
  • Paskins Z, Whittle R, Sultan AA, Muller S, Blagojevic-Bucknall M, Helliwell T, Hider S, Roddy E, Mallen C. 2018. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study. BMC Med, vol. 16(1), 4. link> doi> full text>
  • Liddle J, Bartlam R, Mallen CD, Mackie SL, Prior JA, Helliwell T, Richardson JC. 2017. What is the impact of giant cell arteritis on patients' lives? A UK qualitative study. BMJ Open, vol. 7(8), e017073. link> doi> full text>
  • Prior JA, Ranjbar H, Belcher J, Mackie SL, Helliwell T, Liddle J, Mallen CD. 2017. Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis. BMC Med, vol. 15(1), 120. link> doi> full text>
  • Cawley A, Prior JA, Muller S, Helliwell T, Hider SL, Dasgupta B, Barraclough K, Mallen CD. 2018. Association between characteristics of pain and stiffness and the functional status of patients with incident polymyalgia rheumatica from primary care. Clin Rheumatol, vol. 37(6), 1639-1644. link> doi> full text>
  • Masson W, Muller S, Whittle R, Prior J, Helliwell T, Mallen C, Hider SL. 2017. Possible giant cell arteritis symptoms are common in newly diagnosed patients with Polymyalgia Rheumatica: results from an incident primary care PMR cohort. BMC Rheumatol, vol. 1, 7. link> doi>
  • Muller S, Hider SL, Helliwell T, Lawton S, Barraclough K, Dasgupta B, Zwierska I, Mallen CD. 2016. Characterising those with incident polymyalgia rheumatica in primary care: results from the PMR Cohort Study. Arthritis Res Ther, vol. 18, 200. link> doi> full text>
  • Helliwell T, Brouwer E, Pease CT, Hughes R, Hill CL, Neill LM, Halls S, Simon LS, Mallen CD, Boers M, Kirwan JR, Mackie SL. 2016. Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group. J Rheumatol, vol. 43(1), 182-186. link> doi>
  • Mackie S, Helliwell T, Hughes R, Brouwer E, Pease CT, Mallen C, Boers M, Kirwan JR. 2014. Core Outcome Domains and Potential Measurement Instruments in polymyalgia Rheumatica (PMR) Using Omeract Filter 2.0. ARTHRITIS & RHEUMATOLOGY, vol. 66, S1208-S1209. link>
  • Muller S, Hider SL, Belcher J, Helliwell T, Mallen CD. 2014. Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database. Annals of the Rheumatic Diseases, vol. 73(10), 1769-1773. link> doi> link> full text>
  • Hancock AT, Mallen CD, Muller S, Belcher J, Roddy E, Helliwell T, Hider SL. 2014. Risk of vascular events in patients with polymyalgia rheumatica. CMAJ, vol. 186(13), E495-E501. link> doi>
  • Helliwell T, Mallen C, Peat G, Hay E. 2014. Research into practice: improving musculoskeletal care in general practice. Br J Gen Pract, vol. 64(624), 372-374. link> doi>
  • Helliwell T, Muller S, Hider SL, Mallen CD. 2013. HOW GENERAL PRACTITIONERS DIAGNOSE POLYMYALGIA RHEUMATICA. ANNALS OF THE RHEUMATIC DISEASES, vol. 72, 155. link>
  • Helliwell T, Muller S, Hider SL, Mallen CD. 2013. HOW GENERAL PRACTITIONERS DIAGNOSE POLYMYALGIA RHEUMATICA. ANNALS OF THE RHEUMATIC DISEASES, vol. 72, 1044. link>
  • Helliwell T, Hider SL, Mallen CD. 2013. Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice. Br J Gen Pract, vol. 63(610), e361-e366. link> doi>
  • Helliwell T, Hider S, Barraclough K, Dasgupta B, Mallen C. 2012. Diagnosis and management of polymyalgia rheumatica Response. BRITISH JOURNAL OF GENERAL PRACTICE, vol. 62(600), 348. link> doi>
  • Muller S, Hider S, Helliwell T, Bailey J, Barraclough K, Cope L, Dasgupta B, Foskett R, Hughes R, Mayson Z, Purcell C, Roddy E, Wathall S, Zwierska I, Mallen CD. 2012. The epidemiology of polymyalgia rheumatica in primary care: a research protocol. BMC Musculoskelet Disord, vol. 13, 102. link> doi> full text>
  • Barraclough K, Mallen CD, Helliwell T, Hider SL, Dasgupta B. 2012. Diagnosis and management of giant cell arteritis. Br J Gen Pract, vol. 62(599), 329-330. link> doi>
  • Helliwell T, Hider SL, Barraclough K, Dasgupta B, Mallen CD. 2012. Diagnosis and management of polymyalgia rheumatica. Br J Gen Pract, vol. 62(598), 275-276. link> doi>
  • Helliwell T, Muller S, Hider S. 2012. RAISED INFLAMMATORY MARKERS ESR can be normal in giant cell arteritis and polymyalgia rheumatica. BRITISH MEDICAL JOURNAL, vol. 344, Article ARTN e1408. link> doi>
  • Muller S, Hider SL, Helliwell T, Mallen CD. 2012. An unorthodox approach to calculating sample size. BMJ, vol. 345, e6586. link> doi>
  • Helliwell T, Muller S, Hider S. 2012. ESR can be normal in giant cell arteritis and polymyalgia rheumatica. BMJ, vol. 344, e1408. link> doi>

Other

  • Sultan AA, Whittle R, Muller S, Roddy E, Mallen C, Blagojevic-Bucknall M, Helliwell T, Hider S, Paskins Z. 2017. RISK OF FRACTURE AMONG PATIENTS WITH GOUT: A POPULATION-BASED COHORT STUDY. ANNALS OF THE RHEUMATIC DISEASES (vol. 76, p. 751). link> doi>
  • Paskins Z, Whittle R, Sultan AA, Muller S, Blagojevic-Bucknall M, Helliwell T, Hider S, Roddy E, Mallen C. 2017. RISK OF FRAGILITY FRACTURE AMONG PATIENTS WITH PSORIASIS: A POPULATION BASED MATCHED COHORT STUDY FROM THE UNITED KINGDOM. ANNALS OF THE RHEUMATIC DISEASES (vol. 76, pp. 1028-1029). link> doi>
  • Hider SL, Muller S, Prior J, Helliwell T, Van Schaardenburg D, van der Helm-van Mil A, Raza K, Mallen CD. 2017. SYMPTOMS INDICATIVE OF INFLAMMATORY ARTHRITIS ARE COMMON IN THE PRIMARY CARE POPULATION: FINDINGS FROM THE SYMPTOMS IN PERSONS AT RISK OF RHEUMATOID ARTHRITIS SURVEY. ANNALS OF THE RHEUMATIC DISEASES (vol. 76, p. 1043). link> doi>
  • Liddle J, Bartlam R, Richardson JC, Helliwell T, Mackie S, Prior JA, Mallen CD. 2017. MY WHOLE LIFE IS ALTERED CONSIDERABLY: LIVING WITH THE ONGOING EFFECTS OF GIANT CELL ARTERITIS SYMPTOMS AND TREATMENTS. RHEUMATOLOGY (vol. 56, p. 120). link>
  • Paskins Z, Whittle R, Hider S, Sultan AA, Bucknall M, Helliwell T, Roddy E, Mallen CD. 2017. RISK OF FRAGILITY FRACTURE OVER 10 YEARS IN POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS: A UK POPULATION STUDY. RHEUMATOLOGY (vol. 56, pp. 85-86). link>
  • Helliwell T. 2016. POLYMYALGIA RHEUMATICA: IMPROVING OUTCOMES FOR PATIENTS IN PRIMARY CARE. ANNALS OF THE RHEUMATIC DISEASES (vol. 75, p. 42). link> doi>
  • Muller S, Masson W, Hider SL, Helliwell T, Lawton S, Prior J, Zwierska I, Barraclough K, Dasgupta B, Mallen CD. 2016. HOW COMMON ARE GIANT CELL ARTERITIS SYMPTOMS IN PATIENTS WITH POLYMYALGIA RHEUMATICA? RESULTS FROM AN INCIDENT PRIMARY CARE COHORT. RHEUMATOLOGY (vol. 55, p. 77). link>
  • Prior JA, Muller S, Helliwell T, Hider S, Dasgupta B, Mallen CD. 2016. THE ROLE OF PAIN AND STIFFNESS ON FATIGUE AND INSOMNIA IN AN INCIDENT POLYMYALGIA RHEUMATICA COHORT. RHEUMATOLOGY (vol. 55, p. 82). link>
  • Helliwell T, Muller S, Hider SL, Richardson J, Mallen C. 2015. HOW DO GENERAL PRACTITIONERS MANAGE SUSPECTED GIANT CELL ARTERITIS. RHEUMATOLOGY (vol. 54, p. 168). link>
  • Helliwell T, Muller S, Hider SL, Richardson J, Mallen C. 2014. HOW DO GENERAL PRACTITIONERS IDENTIFY GIANT CELL ARTERITIS (GCA)?. ANNALS OF THE RHEUMATIC DISEASES (vol. 73, p. 1004). link> doi>
  • Helliwell T. 2014. HOW DO GPS MANAGE GIANT CELL ARTERITIS (GCA): A PRIMARY CARE SURVEY. ANNALS OF THE RHEUMATIC DISEASES (vol. 73, pp. 1004-1005). link> doi>
  • Muller S, Mallen CD, Belcher J, Helliwell T, Hider SL. 2013. THE RISK OF A SUBSEQUENT CANCER DIAGNOSIS AFTER PMR: A PRIMARY CARE DATABASE STUDY. RHEUMATOLOGY (vol. 52, p. 40). link>